105 related articles for article (PubMed ID: 22503892)
21. MRS study of meningeal hemangiopericytoma and edema: a comparison with meningothelial meningioma.
Righi V; Tugnoli V; Mucci A; Bacci A; Bonora S; Schenetti L
Oncol Rep; 2012 Oct; 28(4):1461-7. PubMed ID: 22824994
[TBL] [Abstract][Full Text] [Related]
22. Hippocampal sclerosis: MR prediction of seizure intractability.
Briellmann RS; Mark Wellard R; Masterton RA; Abbott DF; Berkovic SF; Jackson GD
Epilepsia; 2007 Feb; 48(2):315-23. PubMed ID: 17295625
[TBL] [Abstract][Full Text] [Related]
23. Magnetic resonance spectroscopic evaluation of brain tissue metabolism after irradiation for pediatric brain tumors in long-term survivors: a report of two cases.
Blamek S; Wydmański J; Sokół M; Matulewicz L; Boguszewicz L
Acta Neurochir Suppl; 2010; 106():191-4. PubMed ID: 19812947
[TBL] [Abstract][Full Text] [Related]
24. Valproate-induced metabolic changes in patients with epilepsy: assessment with H-MRS.
Garcia M; Huppertz HJ; Ziyeh S; Buechert M; Schumacher M; Mader I
Epilepsia; 2009 Mar; 50(3):486-92. PubMed ID: 19183221
[TBL] [Abstract][Full Text] [Related]
25. Time-resolved functional 1H MR spectroscopic detection of glutamate concentration changes in the brain during acute heat pain stimulation.
Gussew A; Rzanny R; Erdtel M; Scholle HC; Kaiser WA; Mentzel HJ; Reichenbach JR
Neuroimage; 2010 Jan; 49(2):1895-902. PubMed ID: 19761852
[TBL] [Abstract][Full Text] [Related]
26. In vivo localized 1H MR spectroscopy of rat testes: stimulated echo acquisition mode (STEAM) combined with short TI inversion recovery (STIR) improves the detection of metabolite signals.
Yamaguchi M; Mitsumori F; Watanabe H; Takaya N; Minami M
Magn Reson Med; 2006 Apr; 55(4):749-54. PubMed ID: 16506155
[TBL] [Abstract][Full Text] [Related]
27. Traumatic brain injury and subarachnoid hemorrhage: in vivo occult pathology demonstrated by magnetic resonance spectroscopy may not be "ischaemic". A primary study and review of the literature.
Macmillan CS; Wild JM; Wardlaw JM; Andrews PJ; Marshall I; Easton VJ
Acta Neurochir (Wien); 2002 Sep; 144(9):853-62; discussion 862. PubMed ID: 12376766
[TBL] [Abstract][Full Text] [Related]
28. Proton T2 relaxation time of J-coupled cerebral metabolites in rat brain at 9.4 T.
Xin L; Gambarota G; Mlynárik V; Gruetter R
NMR Biomed; 2008 May; 21(4):396-401. PubMed ID: 17907262
[TBL] [Abstract][Full Text] [Related]
29. Proton magnetic resonance spectroscopy of normal human brain and glioma: a quantitative in vivo study.
Tong ZY; Toshiaki Y; Wang YJ
Chin Med J (Engl); 2005 Aug; 118(15):1251-7. PubMed ID: 16117877
[TBL] [Abstract][Full Text] [Related]
30. TE-averaged two-dimensional proton spectroscopic imaging of glutamate at 3 T.
Srinivasan R; Cunningham C; Chen A; Vigneron D; Hurd R; Nelson S; Pelletier D
Neuroimage; 2006 May; 30(4):1171-8. PubMed ID: 16431138
[TBL] [Abstract][Full Text] [Related]
31. Alanine peak in central neurocytomas on proton MR spectroscopy.
Krishnamoorthy T; Radhakrishnan VV; Thomas B; Jeyadevan ER; Menon G; Nair S
Neuroradiology; 2007 Jul; 49(7):551-4. PubMed ID: 17364196
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic value of proton MR spectroscopy in peripheral arterial occlusive disease: a prospective evaluation.
Stueckle CA; Claeys L; Haegele K; Zimmermann S; Mruck S; Adams S; Liermann D
AJR Am J Roentgenol; 2006 Nov; 187(5):1322-6. PubMed ID: 17056923
[TBL] [Abstract][Full Text] [Related]
33. Using ex vivo proton magnetic resonance spectroscopy to reveal associations between biochemical and biological features of meningiomas.
Pfisterer WK; Nieman RA; Scheck AC; Coons SW; Spetzler RF; Preul MC
Neurosurg Focus; 2010 Jan; 28(1):E12. PubMed ID: 20043716
[TBL] [Abstract][Full Text] [Related]
34. MR spectroscopic evaluation of N-acetylaspartate's T2 relaxation time and concentration corroborates white matter abnormalities in schizophrenia.
Tunc-Skarka N; Weber-Fahr W; Hoerst M; Meyer-Lindenberg A; Zink M; Ende G
Neuroimage; 2009 Nov; 48(3):525-31. PubMed ID: 19573608
[TBL] [Abstract][Full Text] [Related]
35. Diffusion weighted MR imaging and proton MR spectroscopy findings of central neurocytoma with pathological correlation.
Tlili-Graiess K; Mama N; Arifa N; Kadri K; Hasni I; Krifa H; Mokni M
J Neuroradiol; 2014 Oct; 41(4):243-50. PubMed ID: 24238840
[TBL] [Abstract][Full Text] [Related]
36. Utilization of glutamate/creatine ratios for proton spectroscopic diagnosis of meningiomas.
Hazany S; Hesselink JR; Healy JF; Imbesi SG
Neuroradiology; 2007 Feb; 49(2):121-7. PubMed ID: 17086406
[TBL] [Abstract][Full Text] [Related]
37. In vivo 1H magnetic resonance spectroscopic measurement of brain glycine levels in nonketotic hyperglycinemia.
Gabis L; Parton P; Roche P; Lenn N; Tudorica A; Huang W
J Neuroimaging; 2001 Apr; 11(2):209-11. PubMed ID: 11296595
[TBL] [Abstract][Full Text] [Related]
38. Metabolite detection of pancreatic carcinoma by in vivo proton MR spectroscopy at 3T: initial results.
Yao X; Zeng M; Wang H; Fei S; Rao S; Ji Y
Radiol Med; 2012 Aug; 117(5):780-8. PubMed ID: 22095426
[TBL] [Abstract][Full Text] [Related]
39. (201)Tl-SPECT, (1)H-MRS, and MIB-1 labeling index of central neurocytomas: three case reports.
Kanamori M; Kumabe T; Shimizu H; Yoshimoto T
Acta Neurochir (Wien); 2002 Feb; 144(2):157-63; discussion 163. PubMed ID: 11862516
[TBL] [Abstract][Full Text] [Related]
40. Proton spectroscopy in HIV infection: relaxation times of cerebral metabolites.
Wilkinson ID; Paley M; Chong WK; Sweeney BJ; Shepherd JK; Kendall BE; Hall-Craggs MA; Harrison MJ
Magn Reson Imaging; 1994; 12(6):951-7. PubMed ID: 7968294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
